" />
PhenX - health impact of inflammatory bowel disease protocol 190701:-:Pt: Patient:-:PhenX - CISMeF
PhenX - health impact of inflammatory bowel disease protocol 190701:-:Pt: Patient:-:PhenXLOINC code
Preferred Label : PhenX - health impact of inflammatory bowel disease protocol 190701:-:Pt: Patient:-:PhenX;
LOINC status : TRIAL;
LOINC long common name : PhenX - health impact of inflammatory bowel disease protocol 190701;
LOINC short name : Health impact of inflamm bowel proto;
LOINC description : The Short Inflammatory Bowel Disease Questionnaire (SIBDQ) obtains a clinical status
in respondents who have been diagnosed with inflammatory bowel disease (IBD) (e.g.,
Crohn's disease and ulcerative colitis) using measures of health-related quality of
life over the past 2 weeks. The protocol contains 10 questions that query the well-being
of respondents in four realms relevant to IBD's impact on their lives: emotional,
social, bowel, and work. The questionnaire can be completed in less than 5 minutes.
Because the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) should be administered
to people who have already been diagnosed with Inflammatory Bowel Disease (IBD), the
Gastrointestinal Working Group recommends including a filter question prior to administering
the questionnaire. The filter question should ask if the subject has ever been diagnosed
with inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. Administer
the SIBDQ only if the subject answers Yes to this question. To further classify an
IBD diagnosis, the Gastrointestinal Working Group (WG) recommends using the National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium
Phenotype Form in the Supplemental Information section for the Gastrointestinal WG.;
Has component